Hakutulokset - Daan P. Hurkmans

  • Näytetään 1 - 8 yhteensä 8 tuloksesta
Tarkenna hakua
  1. 1
    Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma

    Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma Tekijä Daan P. Hurkmans, Christina Jensen, Stijn L.W. Koolen, Joachim G.J.V. Aerts, M.A. Karsdal, Ron H.J. Mathijssen, Nicholas Willumsen

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma

    PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma Tekijä Jinfeng Cao, Niels J. Brouwer, Kate Richards, Marina Marinkovic, Sjoerd G. van Duinen, Daan P. Hurkmans, Els M.E. Verdegaal, Ekaterina S. Jordanova, Martine J. Jager

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients

    Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients Tekijä Daan P. Hurkmans, Merian E. Kuipers, Jasper Smit, Ronald van Marion, Ron H.J. Mathijssen, Piet E. Postmus, Pieter S. Hiemstra, Joachim G.J.V. Aerts, Jan H. von der Thüsen, Sjoerd H. van der Burg

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab

    CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab Tekijä André Kunert, Edwin A. Basak, Daan P. Hurkmans, Hayri E. Balcıoğlu, Yarne Klaver, Mandy van Brakel, Astrid A. M. Oostvogels, C. B. H. W. Lamers, Sander Bins, Stijn L.W. Koolen, Astrid A.M. van der Veldt, Stefan Sleijfer, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Reno Debets

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

    Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer Tekijä Daan P. Hurkmans, Edwin A. Basak, Nina Schepers, Esther Oomen‐de Hoop, Cor H. van der Leest, Samira El Bouazzaoui, Sander Bins, Stijn L.W. Koolen, Stefan Sleijfer, Astrid A.M. van der Veldt, Reno Debets, Ron H. N. van Schaik, Joachim G.J.V. Aerts, Ron H.J. Mathijssen

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen

    Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen Tekijä Koen G. A. M. Hussaarts, Daan P. Hurkmans, Esther Oomen–de Hoop, Leonie J. van Harten, Stan Berghuis, Robbert J. van Alphen, Leontine E.A.M.M. Spierings, Quirine C. van Rossum‐Schornagel, Mijntje B. Vastbinder, Ron H. N. van Schaik, Teun van Gelder, Agnes Jager, Roelof W. F. van Leeuwen, Ron H.J. Mathijssen

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

    A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients Tekijä Daan P. Hurkmans, Edwin A. Basak, Tanja van Dijk, Darlene Mercieca, Marco W.J. Schreurs, Annemarie Wijkhuijs, Sander Bins, Esther Oomen‐de Hoop, Reno Debets, Markus Joerger, Arlette E. Odink, Astrid A.M. van der Veldt, Cor H. van der Leest, Joachim G.J.V. Aerts, Ron H.J. Mathijssen, Stijn L.W. Koolen

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

    Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types Tekijä Nicholas Willumsen, Christina Jensen, George Green, Neel I. Nissen, Jaclyn Neely, David M. Nelson, Rasmus S. Pedersen, Peder Frederiksen, Inna M. Chen, Mogens K. Boisen, Astrid Z. Johansen, Daniel H. Madsen, Inge Marie Svane, Allan Lipton, Kim Leitzel, Suhail M. Ali, Janine T. Erler, Daan P. Hurkmans, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Mohammed Eslam, Jacob George, Claus Christiansen, Mina J. Bissel, M.A. Karsdal

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: